678 related articles for article (PubMed ID: 27296438)
1. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine.
Kishida N; Matsuda S; Itano O; Shinoda M; Kitago M; Yagi H; Abe Y; Hibi T; Masugi Y; Aiura K; Sakamoto M; Kitagawa Y
BMC Gastroenterol; 2016 Jun; 16(1):61. PubMed ID: 27296438
[TBL] [Abstract][Full Text] [Related]
2. Microbiome, fibrosis and tumor networks in a non-alcoholic steatohepatitis model of a choline-deficient high-fat diet using diethylnitrosamine.
Yamamoto K; Honda T; Yokoyama S; Ma L; Kato A; Ito T; Ishizu Y; Kuzuya T; Nakamura M; Kawashima H; Ishigami M; Tsuji NM; Fujishiro M
Dig Liver Dis; 2021 Nov; 53(11):1443-1450. PubMed ID: 33726979
[TBL] [Abstract][Full Text] [Related]
3. Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model.
Orime K; Shirakawa J; Togashi Y; Tajima K; Inoue H; Nagashima Y; Terauchi Y
Eur J Pharmacol; 2016 Feb; 772():22-32. PubMed ID: 26724391
[TBL] [Abstract][Full Text] [Related]
4. A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis.
Ejima C; Kuroda H; Ishizaki S
Physiol Rep; 2016 Nov; 4(21):. PubMed ID: 27821715
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice.
Chiba T; Suzuki S; Sato Y; Itoh T; Umegaki K
PLoS One; 2016; 11(10):e0164191. PubMed ID: 27723801
[TBL] [Abstract][Full Text] [Related]
6. Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle.
Dowman JK; Hopkins LJ; Reynolds GM; Nikolaou N; Armstrong MJ; Shaw JC; Houlihan DD; Lalor PF; Tomlinson JW; Hübscher SG; Newsome PN
Am J Pathol; 2014 May; 184(5):1550-61. PubMed ID: 24650559
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency.
Toriguchi K; Hatano E; Tanabe K; Takemoto K; Nakamura K; Koyama Y; Seo S; Taura K; Uemoto S
J Gastroenterol Hepatol; 2014 May; 29(5):1109-18. PubMed ID: 24329600
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.
Ikawa-Yoshida A; Matsuo S; Kato A; Ohmori Y; Higashida A; Kaneko E; Matsumoto M
Int J Exp Pathol; 2017 Aug; 98(4):221-233. PubMed ID: 28895242
[TBL] [Abstract][Full Text] [Related]
9. Early-Life Exposure to Low-Dose Cadmium Accelerates Diethylnitrosamine and Diet-Induced Liver Cancer.
Men H; Young JL; Zhou W; Zhang H; Wang X; Xu J; Lin Q; Tan Y; Zheng Y; Cai L
Oxid Med Cell Longev; 2021; 2021():1427787. PubMed ID: 34876963
[TBL] [Abstract][Full Text] [Related]
10. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
11. Hepatic lipid profile in mice fed a choline-deficient, low-methionine diet resembles human non-alcoholic fatty liver disease.
Haberl EM; Pohl R; Rein-Fischboeck L; Höring M; Krautbauer S; Liebisch G; Buechler C
Lipids Health Dis; 2020 Dec; 19(1):250. PubMed ID: 33298075
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice.
Luo F; Ishigami M; Achiwa K; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Ishikawa T; Katano Y; Goto H
Dig Dis Sci; 2015 Sep; 60(9):2730-9. PubMed ID: 25868633
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking water.
Liu XJ; Duan NN; Liu C; Niu C; Liu XP; Wu J
Lab Invest; 2018 Sep; 98(9):1184-1199. PubMed ID: 29959418
[TBL] [Abstract][Full Text] [Related]
14. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
15. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
17. Hepalatide ameliorated progression of nonalcoholic steatohepatitis in mice.
Liu XJ; Liu C; Zhu LY; Fan CL; Niu C; Liu XP; Liu HL; Wu J
Biomed Pharmacother; 2020 Jun; 126():110053. PubMed ID: 32200254
[TBL] [Abstract][Full Text] [Related]
18. Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis.
Yoshimine Y; Uto H; Kumagai K; Mawatari S; Arima S; Ibusuki R; Mera K; Nosaki T; Kanmura S; Numata M; Tamai T; Moriuchi A; Tsubouchi H; Ido A
Oncol Rep; 2015 Apr; 33(4):1657-66. PubMed ID: 25607821
[TBL] [Abstract][Full Text] [Related]
19. Models of nonalcoholic steatohepatitis potentiated by chemical inducers leading to hepatocellular carcinoma.
Márquez-Quiroga LV; Arellanes-Robledo J; Vásquez-Garzón VR; Villa-Treviño S; Muriel P
Biochem Pharmacol; 2022 Jan; 195():114845. PubMed ID: 34801522
[TBL] [Abstract][Full Text] [Related]
20. A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.
Tucker RD; Ciofoaia V; Nadella S; Gay MD; Cao H; Huber M; Safronenka A; Shivapurkar N; Kallakury B; Kruger AJ; Kroemer AHK; Smith JP
Dig Dis Sci; 2020 Jan; 65(1):189-203. PubMed ID: 31297627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
